カテゴリ： QYResearch, 世界, 医療/バイオ

ドフェティリドの世界市場2023年：カプセル、その他

■ 英語タイトル：Global Dofetilide Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8742）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8742
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：88
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[ドフェティリドの世界市場2023年：カプセル、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料はドフェティリドのグローバル市場について調査・分析し、世界のドフェティリド市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（カプセル、その他）、用途別セグメント分析（病院、クリニック）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Sigmapharm Laboratories、Mayne Pharma、Novadoz Pharmaceuticals、Pfizer、NorthStar Rx LLC、AvKARE, Inc.、Accord Healthcare、Bionpharma、Sun Pharmaceutical Industries Ltd.などが含まれています。ドフェティリドのグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、ドフェティリド市場規模を算出する際に考慮しました。

・ドフェティリド市場の概要
- 製品の定義
- ドフェティリドの種類別セグメント
- 世界のドフェティリド市場規模：タイプ別分析（カプセル、その他）
- ドフェティリドの用途別セグメント
- 世界のドフェティリド市場規模：用途別分析（病院、クリニック）
- 世界のドフェティリド市場規模予測（2018年-2029年）
- ドフェティリドの平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- ドフェティリド市場の競争状況およびトレンド

・ドフェティリドの地域別市場規模
- 北米のドフェティリド市場規模（2018年-2029年）
- 米国のドフェティリド市場規模（2018年-2029年）
- ヨーロッパのドフェティリド市場規模（2018年-2029年）
- アジア太平洋のドフェティリド市場規模（2018年-2029年）
- 中国のドフェティリド市場規模（2018年-2029年）
- 日本のドフェティリド市場規模（2018年-2029年）
- 韓国のドフェティリド市場規模（2018年-2029年）
- インドのドフェティリド市場規模（2018年-2029年）
- オーストラリアのドフェティリド市場規模（2018年-2029年）
- 中南米のドフェティリド市場規模（2018年-2029年）
- 中東・アフリカのドフェティリド市場規模（2018年-2029年）

・種類別セグメント：カプセル、その他
- 世界のドフェティリドのタイプ別販売量（2018年-2023年）
- 世界のドフェティリドのタイプ別売上（2018年-2023年）
- 世界のドフェティリドのタイプ別価格

・用途別セグメント：病院、クリニック
- 世界のドフェティリドの用途別販売量（2018年-2023年）
- 世界のドフェティリドの用途別売上（2018年-2023年）
- 世界のドフェティリドの用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Sigmapharm Laboratories、Mayne Pharma、Novadoz Pharmaceuticals、Pfizer、NorthStar Rx LLC、AvKARE, Inc.、Accord Healthcare、Bionpharma、Sun Pharmaceutical Industries Ltd.

・産業チェーンと販売チャネルの分析
- ドフェティリド産業チェーン分析
- ドフェティリドの主要原材料
- ドフェティリドの販売チャネル
- ドフェティリドのディストリビューター
- ドフェティリドの主要顧客

・ドフェティリド市場ダイナミクス
- ドフェティリドの業界動向
- ドフェティリド市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Dofetilide is a class III antiarrhythmic agent.
Highlights
The global Dofetilide market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Dofetilide is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Dofetilide is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Dofetilide include Sigmapharm Laboratories, Mayne Pharma, Novadoz Pharmaceuticals, Pfizer, NorthStar Rx LLC, AvKARE, Inc., Accord Healthcare, Bionpharma and Sun Pharmaceutical Industries Ltd., etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Dofetilide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dofetilide.
The Dofetilide market size, estimations, and forecasts are provided in terms of sales volume (K Bottles) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Dofetilide market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dofetilide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Sigmapharm Laboratories
Mayne Pharma
Novadoz Pharmaceuticals
Pfizer
NorthStar Rx LLC
AvKARE, Inc.
Accord Healthcare
Bionpharma
Sun Pharmaceutical Industries Ltd.
Segment by Type
Capsules
Others
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dofetilide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Dofetilide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Dofetilide Market Overview
1.1 Product Overview and Scope of Dofetilide
1.2 Dofetilide Segment by Type
1.2.1 Global Dofetilide Market Value Comparison by Type (2023-2029)
1.2.2 Capsules
1.2.3 Others
1.3 Dofetilide Segment by Application
1.3.1 Global Dofetilide Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Dofetilide Market Size Estimates and Forecasts
1.4.1 Global Dofetilide Revenue 2018-2029
1.4.2 Global Dofetilide Sales 2018-2029
1.4.3 Global Dofetilide Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Dofetilide Market Competition by Manufacturers
2.1 Global Dofetilide Sales Market Share by Manufacturers (2018-2023)
2.2 Global Dofetilide Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Dofetilide Average Price by Manufacturers (2018-2023)
2.4 Global Dofetilide Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Dofetilide, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dofetilide, Product Type & Application
2.7 Dofetilide Market Competitive Situation and Trends
2.7.1 Dofetilide Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Dofetilide Players Market Share by Revenue
2.7.3 Global Dofetilide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Dofetilide Retrospective Market Scenario by Region
3.1 Global Dofetilide Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Dofetilide Global Dofetilide Sales by Region: 2018-2029
3.2.1 Global Dofetilide Sales by Region: 2018-2023
3.2.2 Global Dofetilide Sales by Region: 2024-2029
3.3 Global Dofetilide Global Dofetilide Revenue by Region: 2018-2029
3.3.1 Global Dofetilide Revenue by Region: 2018-2023
3.3.2 Global Dofetilide Revenue by Region: 2024-2029
3.4 North America Dofetilide Market Facts & Figures by Country
3.4.1 North America Dofetilide Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Dofetilide Sales by Country (2018-2029)
3.4.3 North America Dofetilide Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Dofetilide Market Facts & Figures by Country
3.5.1 Europe Dofetilide Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Dofetilide Sales by Country (2018-2029)
3.5.3 Europe Dofetilide Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dofetilide Market Facts & Figures by Country
3.6.1 Asia Pacific Dofetilide Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Dofetilide Sales by Country (2018-2029)
3.6.3 Asia Pacific Dofetilide Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Dofetilide Market Facts & Figures by Country
3.7.1 Latin America Dofetilide Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Dofetilide Sales by Country (2018-2029)
3.7.3 Latin America Dofetilide Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Dofetilide Market Facts & Figures by Country
3.8.1 Middle East and Africa Dofetilide Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Dofetilide Sales by Country (2018-2029)
3.8.3 Middle East and Africa Dofetilide Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Dofetilide Sales by Type (2018-2029)
4.1.1 Global Dofetilide Sales by Type (2018-2023)
4.1.2 Global Dofetilide Sales by Type (2024-2029)
4.1.3 Global Dofetilide Sales Market Share by Type (2018-2029)
4.2 Global Dofetilide Revenue by Type (2018-2029)
4.2.1 Global Dofetilide Revenue by Type (2018-2023)
4.2.2 Global Dofetilide Revenue by Type (2024-2029)
4.2.3 Global Dofetilide Revenue Market Share by Type (2018-2029)
4.3 Global Dofetilide Price by Type (2018-2029)
5 Segment by Application
5.1 Global Dofetilide Sales by Application (2018-2029)
5.1.1 Global Dofetilide Sales by Application (2018-2023)
5.1.2 Global Dofetilide Sales by Application (2024-2029)
5.1.3 Global Dofetilide Sales Market Share by Application (2018-2029)
5.2 Global Dofetilide Revenue by Application (2018-2029)
5.2.1 Global Dofetilide Revenue by Application (2018-2023)
5.2.2 Global Dofetilide Revenue by Application (2024-2029)
5.2.3 Global Dofetilide Revenue Market Share by Application (2018-2029)
5.3 Global Dofetilide Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Sigmapharm Laboratories
6.1.1 Sigmapharm Laboratories Corporation Information
6.1.2 Sigmapharm Laboratories Description and Business Overview
6.1.3 Sigmapharm Laboratories Dofetilide Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Sigmapharm Laboratories Dofetilide Product Portfolio
6.1.5 Sigmapharm Laboratories Recent Developments/Updates
6.2 Mayne Pharma
6.2.1 Mayne Pharma Corporation Information
6.2.2 Mayne Pharma Description and Business Overview
6.2.3 Mayne Pharma Dofetilide Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Mayne Pharma Dofetilide Product Portfolio
6.2.5 Mayne Pharma Recent Developments/Updates
6.3 Novadoz Pharmaceuticals
6.3.1 Novadoz Pharmaceuticals Corporation Information
6.3.2 Novadoz Pharmaceuticals Description and Business Overview
6.3.3 Novadoz Pharmaceuticals Dofetilide Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Novadoz Pharmaceuticals Dofetilide Product Portfolio
6.3.5 Novadoz Pharmaceuticals Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Dofetilide Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Pfizer Dofetilide Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 NorthStar Rx LLC
6.5.1 NorthStar Rx LLC Corporation Information
6.5.2 NorthStar Rx LLC Description and Business Overview
6.5.3 NorthStar Rx LLC Dofetilide Sales, Revenue and Gross Margin (2018-2023)
6.5.4 NorthStar Rx LLC Dofetilide Product Portfolio
6.5.5 NorthStar Rx LLC Recent Developments/Updates
6.6 AvKARE, Inc.
6.6.1 AvKARE, Inc. Corporation Information
6.6.2 AvKARE, Inc. Description and Business Overview
6.6.3 AvKARE, Inc. Dofetilide Sales, Revenue and Gross Margin (2018-2023)
6.6.4 AvKARE, Inc. Dofetilide Product Portfolio
6.6.5 AvKARE, Inc. Recent Developments/Updates
6.7 Accord Healthcare
6.6.1 Accord Healthcare Corporation Information
6.6.2 Accord Healthcare Description and Business Overview
6.6.3 Accord Healthcare Dofetilide Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Accord Healthcare Dofetilide Product Portfolio
6.7.5 Accord Healthcare Recent Developments/Updates
6.8 Bionpharma
6.8.1 Bionpharma Corporation Information
6.8.2 Bionpharma Description and Business Overview
6.8.3 Bionpharma Dofetilide Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Bionpharma Dofetilide Product Portfolio
6.8.5 Bionpharma Recent Developments/Updates
6.9 Sun Pharmaceutical Industries Ltd.
6.9.1 Sun Pharmaceutical Industries Ltd. Corporation Information
6.9.2 Sun Pharmaceutical Industries Ltd. Description and Business Overview
6.9.3 Sun Pharmaceutical Industries Ltd. Dofetilide Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Sun Pharmaceutical Industries Ltd. Dofetilide Product Portfolio
6.9.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dofetilide Industry Chain Analysis
7.2 Dofetilide Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dofetilide Production Mode & Process
7.4 Dofetilide Sales and Marketing
7.4.1 Dofetilide Sales Channels
7.4.2 Dofetilide Distributors
7.5 Dofetilide Customers
8 Dofetilide Market Dynamics
8.1 Dofetilide Industry Trends
8.2 Dofetilide Market Drivers
8.3 Dofetilide Market Challenges
8.4 Dofetilide Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Dofetilide Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Dofetilide Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Dofetilide Market Competitive Situation by Manufacturers in 2022
Table 4. Global Dofetilide Sales (K Bottles) of Key Manufacturers (2018-2023)
Table 5. Global Dofetilide Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Dofetilide Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Dofetilide Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Dofetilide Average Price (US$/Bottle) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Dofetilide, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Dofetilide, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Dofetilide, Product Type & Application
Table 12. Global Key Manufacturers of Dofetilide, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Dofetilide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dofetilide as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Dofetilide Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Dofetilide Sales by Region (2018-2023) & (K Bottles)
Table 18. Global Dofetilide Sales Market Share by Region (2018-2023)
Table 19. Global Dofetilide Sales by Region (2024-2029) & (K Bottles)
Table 20. Global Dofetilide Sales Market Share by Region (2024-2029)
Table 21. Global Dofetilide Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Dofetilide Revenue Market Share by Region (2018-2023)
Table 23. Global Dofetilide Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Dofetilide Revenue Market Share by Region (2024-2029)
Table 25. North America Dofetilide Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Dofetilide Sales by Country (2018-2023) & (K Bottles)
Table 27. North America Dofetilide Sales by Country (2024-2029) & (K Bottles)
Table 28. North America Dofetilide Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Dofetilide Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Dofetilide Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Dofetilide Sales by Country (2018-2023) & (K Bottles)
Table 32. Europe Dofetilide Sales by Country (2024-2029) & (K Bottles)
Table 33. Europe Dofetilide Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Dofetilide Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Dofetilide Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Dofetilide Sales by Region (2018-2023) & (K Bottles)
Table 37. Asia Pacific Dofetilide Sales by Region (2024-2029) & (K Bottles)
Table 38. Asia Pacific Dofetilide Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Dofetilide Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Dofetilide Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Dofetilide Sales by Country (2018-2023) & (K Bottles)
Table 42. Latin America Dofetilide Sales by Country (2024-2029) & (K Bottles)
Table 43. Latin America Dofetilide Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Dofetilide Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Dofetilide Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Dofetilide Sales by Country (2018-2023) & (K Bottles)
Table 47. Middle East & Africa Dofetilide Sales by Country (2024-2029) & (K Bottles)
Table 48. Middle East & Africa Dofetilide Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Dofetilide Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Dofetilide Sales (K Bottles) by Type (2018-2023)
Table 51. Global Dofetilide Sales (K Bottles) by Type (2024-2029)
Table 52. Global Dofetilide Sales Market Share by Type (2018-2023)
Table 53. Global Dofetilide Sales Market Share by Type (2024-2029)
Table 54. Global Dofetilide Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Dofetilide Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Dofetilide Revenue Market Share by Type (2018-2023)
Table 57. Global Dofetilide Revenue Market Share by Type (2024-2029)
Table 58. Global Dofetilide Price (US$/Bottle) by Type (2018-2023)
Table 59. Global Dofetilide Price (US$/Bottle) by Type (2024-2029)
Table 60. Global Dofetilide Sales (K Bottles) by Application (2018-2023)
Table 61. Global Dofetilide Sales (K Bottles) by Application (2024-2029)
Table 62. Global Dofetilide Sales Market Share by Application (2018-2023)
Table 63. Global Dofetilide Sales Market Share by Application (2024-2029)
Table 64. Global Dofetilide Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Dofetilide Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Dofetilide Revenue Market Share by Application (2018-2023)
Table 67. Global Dofetilide Revenue Market Share by Application (2024-2029)
Table 68. Global Dofetilide Price (US$/Bottle) by Application (2018-2023)
Table 69. Global Dofetilide Price (US$/Bottle) by Application (2024-2029)
Table 70. Sigmapharm Laboratories Corporation Information
Table 71. Sigmapharm Laboratories Description and Business Overview
Table 72. Sigmapharm Laboratories Dofetilide Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2018-2023)
Table 73. Sigmapharm Laboratories Dofetilide Product
Table 74. Sigmapharm Laboratories Recent Developments/Updates
Table 75. Mayne Pharma Corporation Information
Table 76. Mayne Pharma Description and Business Overview
Table 77. Mayne Pharma Dofetilide Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2018-2023)
Table 78. Mayne Pharma Dofetilide Product
Table 79. Mayne Pharma Recent Developments/Updates
Table 80. Novadoz Pharmaceuticals Corporation Information
Table 81. Novadoz Pharmaceuticals Description and Business Overview
Table 82. Novadoz Pharmaceuticals Dofetilide Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2018-2023)
Table 83. Novadoz Pharmaceuticals Dofetilide Product
Table 84. Novadoz Pharmaceuticals Recent Developments/Updates
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Dofetilide Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2018-2023)
Table 88. Pfizer Dofetilide Product
Table 89. Pfizer Recent Developments/Updates
Table 90. NorthStar Rx LLC Corporation Information
Table 91. NorthStar Rx LLC Description and Business Overview
Table 92. NorthStar Rx LLC Dofetilide Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2018-2023)
Table 93. NorthStar Rx LLC Dofetilide Product
Table 94. NorthStar Rx LLC Recent Developments/Updates
Table 95. AvKARE, Inc. Corporation Information
Table 96. AvKARE, Inc. Description and Business Overview
Table 97. AvKARE, Inc. Dofetilide Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2018-2023)
Table 98. AvKARE, Inc. Dofetilide Product
Table 99. AvKARE, Inc. Recent Developments/Updates
Table 100. Accord Healthcare Corporation Information
Table 101. Accord Healthcare Description and Business Overview
Table 102. Accord Healthcare Dofetilide Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2018-2023)
Table 103. Accord Healthcare Dofetilide Product
Table 104. Accord Healthcare Recent Developments/Updates
Table 105. Bionpharma Corporation Information
Table 106. Bionpharma Description and Business Overview
Table 107. Bionpharma Dofetilide Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2018-2023)
Table 108. Bionpharma Dofetilide Product
Table 109. Bionpharma Recent Developments/Updates
Table 110. Sun Pharmaceutical Industries Ltd. Corporation Information
Table 111. Sun Pharmaceutical Industries Ltd. Description and Business Overview
Table 112. Sun Pharmaceutical Industries Ltd. Dofetilide Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2018-2023)
Table 113. Sun Pharmaceutical Industries Ltd. Dofetilide Product
Table 114. Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Dofetilide Distributors List
Table 118. Dofetilide Customers List
Table 119. Dofetilide Market Trends
Table 120. Dofetilide Market Drivers
Table 121. Dofetilide Market Challenges
Table 122. Dofetilide Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Dofetilide
Figure 2. Global Dofetilide Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Dofetilide Market Share by Type in 2022 & 2029
Figure 4. Capsules Product Picture
Figure 5. Others Product Picture
Figure 6. Global Dofetilide Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Dofetilide Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Global Dofetilide Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Dofetilide Market Size (2018-2029) & (US$ Million)
Figure 12. Global Dofetilide Sales (2018-2029) & (K Bottles)
Figure 13. Global Dofetilide Average Price (US$/Bottle) & (2018-2029)
Figure 14. Dofetilide Report Years Considered
Figure 15. Dofetilide Sales Share by Manufacturers in 2022
Figure 16. Global Dofetilide Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Dofetilide Players: Market Share by Revenue in 2022
Figure 18. Dofetilide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Dofetilide Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Dofetilide Sales Market Share by Country (2018-2029)
Figure 21. North America Dofetilide Revenue Market Share by Country (2018-2029)
Figure 22. United States Dofetilide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Dofetilide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Dofetilide Sales Market Share by Country (2018-2029)
Figure 25. Europe Dofetilide Revenue Market Share by Country (2018-2029)
Figure 26. Germany Dofetilide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Dofetilide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. Dofetilide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Dofetilide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Dofetilide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Dofetilide Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Dofetilide Revenue Market Share by Region (2018-2029)
Figure 33. China Dofetilide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Dofetilide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Dofetilide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Dofetilide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Dofetilide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Dofetilide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Indonesia Dofetilide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Thailand Dofetilide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Malaysia Dofetilide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Dofetilide Sales Market Share by Country (2018-2029)
Figure 43. Latin America Dofetilide Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Dofetilide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Dofetilide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Dofetilide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Colombia Dofetilide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Dofetilide Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Dofetilide Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Dofetilide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Dofetilide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Dofetilide Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Dofetilide by Type (2018-2029)
Figure 54. Global Revenue Market Share of Dofetilide by Type (2018-2029)
Figure 55. Global Dofetilide Price (US$/Bottle) by Type (2018-2029)
Figure 56. Global Sales Market Share of Dofetilide by Application (2018-2029)
Figure 57. Global Revenue Market Share of Dofetilide by Application (2018-2029)
Figure 58. Global Dofetilide Price (US$/Bottle) by Application (2018-2029)
Figure 59. Dofetilide Value Chain
Figure 60. Dofetilide Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • ダビガトランエテキシレートカプセルの世界市場2023-2029：110mg/カプセル、150mg/カプセル
  • ダビガトランエテキシレートカプセルのグローバル市場2023：110mg/カプセル、150mg/カプセル
  • 活性炭栄養補助食品の世界市場2023年：カプセル、錠剤、その他
  • 新型コロナ抗ウイルス経口薬品の世界市場2023年：錠剤、カプセル
  • カプセル/錠剤用印刷インキの世界市場2023年：溶剤系、水系
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8742 )"ドフェティリドの世界市場2023年：カプセル、その他" (英文：Global Dofetilide Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。